Skip to main content

Pharma News

academics

 

Clinical research courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • DNA Repair Discovery Could Improve Biotechnology

    Veterinarian, immunologist, and molecular geneticist Dr. Kathy Meek and her team from the Michigan State University College of Veterinary Medicine have made a discovery that may have implications for therapeutic gene editing strategies, cancer diagnostics and therapies, and other aspects of biotechnology.

  • Seizures can be predicted more than 30 minutes before onset in patients with temporal lobe epilepsy : Study

    Seizures can be predicted more than 30 minutes before onset in patients with temporal lobe epilepsy, opening the door to a therapy using electrodes that could be activated to prevent seizures from happening, according to new research from UTHealth Houston.

    The study, led by Sandipan Pati, MD, associate professor in the Department of Neurology with McGovern Medical School at UTHealth Houston, was recently published in NEJM Evidence, a publication of the New England Journal of Medicine.

  • Gambia children deaths are associated with syrup made by Maiden Pharmaceuticals, says US CDC

    Centers for Disease Control and Prevention (CDC) US researchers said that the Gambia children deaths are associated with syrup made by Maiden Pharmaceuticals. Their investigation strongly suggests that medications contaminated with diethylene glycol (DEG) or ethylene glycol (EG) imported into The Gambia led to this acute kidney injury (AKI) cluster among children.

  • Hetero group to invest Rs. 1000 crore in Andhra Pradesh

    Hetero group to invest Rs. 1000 crore in Andhra Pradesh to expand its pharmaceutical and specialist business, said Vamsi Krishna Bandi, Managing Director of Hetero.

    There was Global Investors Summit 2023 organised at Visakhapatnam where he said, "We are committed to Andhra Pradesh and will continue to expand our presence here. We'll be investing about Rs 1,000 crore in Andhra Pradesh over the next two years to grow our pharmaceutical and specialty business. This will generate employment for a minimum of 3,000 people."

  • Zydus receives approval from USFDA for Apixaban Tablets, 2.5 mg and 5 mg

    Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Apixaban Tablets, 2.5 mg and 5 mg (USRLD: Eliquis® Tablets).

  • Granules India Limited Received ANDA approval for Losartan Potassium Tablets

    Granules India Limited announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Losartan Potassium Tablets USP, 25 mg, 50 mg, and 100 mg.

    It is bioequivalent to the reference listed drug product (RLD), Cozaar Tablets of Organon LLC. Granules now has a total of 54 ANDA approvals from US FDA (52 Final approvals and 2 tentative approvals).

  • Dr. Reddys Lab acquire US business of Mayne Pharma

    Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories Ltd announced that it has entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Salisbury, Australia, based Mayne Pharma Group Limited.

  • Workshop on Biomedical Waste Management Rules, 2016 for doctors and staff of SMS Medical College

    In association with IIHMR University, Jaipur, Rajasthan State Pollution Control Board organized a Workshop on Biomedical Waste Management Rules, 2016 for doctors and staff of SMS Medical College – Attached Hospitals" on Thursday, February 16, 2023. The workshop was held at the SMS Auditorium in Jaipur and was attended by more than 100 participants. 

  • Tablet-based screening doubles detection of psychosis symptoms in youth

    Asking patients to take a short survey on a tablet before their appointments may help mental health providers identify young people at risk of psychosis. A UC Davis Health study found that when patients took a 21-question pre-visit survey, more than twice as many were identified at risk of psychosis compared to those who did not complete the survey.

  • Establishment of a highly sensitive detection method for imidazole dipeptide oxidation derivatives

    Antioxidants discovered in meat! Osaka Metropolitan University researchers developed a new protocol for selective and highly sensitive detection, discovering five types of 2-oxo-imidazole-containing dipeptides(2-oxo-IDPs) using mass spectrometry. The 2-oxo-IDPs, present in living organisms, exhibit very high antioxidant activity, and were found to be abundant in meat including, beef, pork, and chicken.

Subscribe to Pharma News